UK markets open in 5 hours 8 minutes
NIKKEI 225
39,877.36 +246.30 (+0.62%) HANG SENG
17,795.55 +76.94 (+0.43%) CRUDE OIL
83.51 +0.13 (+0.16%) GOLD FUTURES
2,342.00 +3.10 (+0.13%) DOW
39,169.52 +50.66 (+0.13%) Bitcoin GBP
49,714.53 -503.12 (-1.00%)
Daré Bioscience, Inc. (DARE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 31.93M |
| Enterprise value | 29.94M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.21 |
| Price/book (mrq) | 3.44 |
| Enterprise value/revenue | 10.63 |
| Enterprise value/EBITDA | -2.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.35 |
| 52-week change 3 | -65.29% |
| S&P500 52-week change 3 | 23.12% |
| 52-week high 3 | 11.0376 |
| 52-week low 3 | 3.2400 |
| 50-day moving average 3 | 4.7142 |
| 200-day moving average 3 | 4.7745 |
Share statistics
| Avg vol (3-month) 3 | 65.63k |
| Avg vol (10-day) 3 | 79.97k |
| Shares outstanding 5 | 8.42M |
| Implied shares outstanding 6 | 101.09M |
| Float 8 | 8.28M |
| % held by insiders 1 | 1.64% |
| % held by institutions 1 | 6.81% |
| Shares short (14 Jun 2024) 4 | 14.41k |
| Short ratio (14 Jun 2024) 4 | 0.27 |
| Short % of float (14 Jun 2024) 4 | 0.17% |
| Short % of shares outstanding (14 Jun 2024) 4 | 0.17% |
| Shares short (prior month 15 May 2024) 4 | 44.41k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 20 Jul 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:12 |
| Last split date 3 | 01 Jul 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -64,743.85% |
Management effectiveness
| Return on assets (ttm) | -81.78% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 2.82M |
| Revenue per share (ttm) | 0.37 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -28.34M |
| Net income avi to common (ttm) | -28.87M |
| Diluted EPS (ttm) | -3.9600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.63M |
| Total cash per share (mrq) | 0.43 |
| Total debt (mrq) | 1.64M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.56 |
| Book value per share (mrq) | -1.31 |
Cash flow statement
| Operating cash flow (ttm) | -29.55M |
| Levered free cash flow (ttm) | -19.19M |
© 2024 Yahoo. All rights reserved.